Advancing aggrecan deficiency research
Short stature and accelerated bone age is common among people with aggrecan gene (ACAN) mutations. Andrew Dauber, M.D., a recipient of the 2019 Human Growth Award, discusses growth-hormone treatment options and ongoing research with 20 families who have this mutation.
About the Expert
Division Chief, Endocrinology Program Director, Endocrinology Fellowship